RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.20
−2.26%0
Insider buys (3m)
4
Insider sells (3m)
-$118.0K
Net value (3m)
+7.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Weinberg Eric · officer: See remarks | M-Exempt | 35,168 | $4.34 |
| Sep 9, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | A-Award | 93,984 | $6.38 |
| Sep 9, 2026 | Weinberg Eric · officer: See remarks | A-Award | 32,258 | $6.38 |
| Sep 9, 2026 | Weinberg Eric · officer: See remarks | A-Award | 93,984 | $6.38 |
| Sep 9, 2026 | Kurtz Ronald M MD · officer: Chief Medical Officer | A-Award | 254,751 | $6.38 |
| Sep 9, 2026 | Kurtz Ronald M MD · officer: Chief Medical Officer | A-Award | 173,913 | $6.38 |
| Sep 9, 2026 | Kurtz Ronald M MD · officer: Chief Medical Officer | A-Award | 96,129 | $6.38 |
| Sep 9, 2026 | Kurtz Ronald M MD · officer: Chief Medical Officer | A-Award | 161,654 | $6.38 |
| Sep 9, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | A-Award | 73,960 | $6.38 |
| Sep 9, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | A-Award | 104,347 | $6.38 |
| Sep 9, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | A-Award | 59,483 | $6.38 |
| Sep 9, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | A-Award | 32,258 | $6.38 |
| Sep 9, 2026 | Wilterding Mark · officer: Chief Financial Officer | A-Award | 258,770 | $6.38 |
| Sep 9, 2026 | Weinberg Eric · officer: See remarks | A-Award | 65,742 | $6.38 |
| Sep 9, 2026 | Weinberg Eric · officer: See remarks | A-Award | 82,608 | $6.38 |
| Sep 9, 2026 | Weinberg Eric · officer: See remarks | A-Award | 59,483 | $6.38 |
| Sep 2, 2026 | Weinberg Eric · officer: See remarks | Sale | 2,041 | $6.96 |
| Sep 2, 2026 | Kurtz Ronald M MD · officer: Chief Medical Officer | M-Exempt | 13,425 | $0.00 |
| Sep 2, 2026 | Kurtz Ronald M MD · officer: Chief Medical Officer | Sale | 5,100 | $6.96 |
| Sep 2, 2026 | Wilterding Mark · officer: Chief Financial Officer | M-Exempt | 20,441 | $0.00 |
| Sep 2, 2026 | Wilterding Mark · officer: Chief Financial Officer | Sale | 7,765 | $6.96 |
| Sep 2, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | M-Exempt | 5,370 | $0.00 |
| Sep 2, 2026 | Goldshleger Ilya · officer: Chief Operating Officer | Sale | 2,041 | $6.96 |
| Sep 2, 2026 | Weinberg Eric · officer: See remarks | M-Exempt | 5,370 | $0.00 |
| Jul 24, 2026 | Mottiwala Aziz · director, officer: President and CEO | A-Award | 2,312,138 | $0.00 |
| Jul 24, 2026 | Mottiwala Aziz · director, officer: President and CEO | A-Award | 571,286 | $5.19 |
| Jun 18, 2026 | Fountain Tamara · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | Andrews Julie · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | Tammenoms Bakker Juliet · director | A-Award | 37,037 | $0.00 |
| Jun 18, 2026 | COHEN RAYMOND W · director | A-Award | 30,864 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 59Increased 136Reduced 89Sold out 36
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 5,790,408 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 3,187,092 | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,030,287 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 2,059,459 | May 15, 2026 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | Reduced | 2,058,684 | May 13, 2026 |
| No Street GP LP | Increased | 2,055,000 | Aug 14, 2026 |
| NOMURA HOLDINGS INC | Unchanged | 2,000,060 | May 15, 2026 |
| NOMURA HOLDINGS INC | Unchanged | 2,000,060 | Aug 14, 2026 |
| NO STREET GP LP | Increased | 2,000,000 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Increased | 1,985,215 | Aug 14, 2026 |
| D. E. SHAW & CO., INC. | Increased | 1,959,732 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,692,935 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 1,675,582 | Aug 13, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 1,533,826 | Aug 14, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,501,180 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 16, 2026